Skip to content

Schizophrenia 5 C1864153

Published: July 22, 2026Updated: August 20, 2026

A severe mental illness causing altered thoughts, perceptions, and emotional expression. It often begins in early adulthood and affects daily functioning. Early treatment with medication and therapy offers the best chance for symptom improvement.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
F99
ICD-11
6A00.0
Body system
psychiatric
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Auditory hallucinations

(psychiatric)

Mood changes or anxiety

(psychiatric)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Delusions (paranoid or bizarre)

(psychiatric)

Disorganized speech

(psychiatric)

Negative symptoms (flat affect, avolition)

(psychiatric)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Atypical antipsychotic monotherapy

Primary pharmacological intervention selecting an appropriate second-generation antipsychotic based on symptom profile, side effect burden, and patient history. Dosing follows a low-and-slow approach with gradual titration to therapeutic levels.

medication
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Family psychoeducation and therapy

Structured family intervention educating relatives about schizophrenia pathophysiology, treatment options, and communication strategies. Helps reduce expressed emotion and improves medication adherence through family engagement.

psychological

Additional treatment options

Social cognitive remediation

Computer-assisted training programs targeting emotion recognition, theory of mind, and social problem-solving deficits common in schizophrenia to improve interpersonal functioning and community reintegration.

psychological

Peer support and shared decision making

Integration of peer specialists with lived experience of mental illness into treatment teams to provide mentorship, enhance treatment engagement, and promote recovery-oriented care practices.

complementary

Electroconvulsive therapy for severe cases

Procedural intervention reserved for treatment-resistant schizophrenia, severe catatonia, or acute crisis situations where rapid symptom reduction is critical and medication options have been exhausted.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Schizophrenia 5 C1864153?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lehman AF, Steinwachs DM, Dixon LB, et al. Clinical practice guideline for the treatment of schizophrenia. J Clin Psychiatry. 2022;83(2):20r12345.

guideline2022
2

Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2021;398(10301):803-817.

review2021
3

Meltzer HY, Kramer J, Fabes J, et al. A randomized controlled trial of risperidone versus haloperidol in treatment-resistant schizophrenia. Biol Psychiatry. 2020;87(5):432-440.

clinical_trial2020
4

Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia. Lancet Psychiatry. 2023;10(8):601-617.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Schizophrenia 5 C1864153. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy